-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Whitehawk Therapeutics, Inc. quarterly/annual Costs and Expenses history and change rate from Q1 2021 to Q3 2025.
- Whitehawk Therapeutics, Inc. Costs and Expenses for the quarter ending 30 Sep 2025 was $19.5M, a 5.23% decline year-over-year.
- Whitehawk Therapeutics, Inc. Costs and Expenses for the twelve months ending 30 Sep 2025 was $123M, a 34.6% increase year-over-year.
- Whitehawk Therapeutics, Inc. annual Costs and Expenses for 2024 was $93.4M, a 2.96% decline from 2023.
- Whitehawk Therapeutics, Inc. annual Costs and Expenses for 2023 was $96.3M, a 23.6% increase from 2022.
- Whitehawk Therapeutics, Inc. annual Costs and Expenses for 2022 was $77.9M, a 30.7% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)